Last reviewed · How we verify

NCT03584074

Clinical Trial of Pregabalin and COX2 in Spinal Stenosis

Status unknown Phase 4 Last updated 12 July 2018
What this trial tests

Phase 4 trial testing Pregabalin 75mg in Spinal Stenosis Lumbar in 60 participants. Status unknown.

Timeline
1 July 2018
Primary endpoint
30 May 2019
31 December 2019

Quick facts

Lead sponsorSeoul National University Bundang Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 July 2018
Primary completion30 May 2019
Estimated completion31 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Bundang Hospital

Who can join

40 and older, any sex, with Spinal Stenosis Lumbar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of this prospective, single-blind, randomized study was to compare the efficacy of the combination of celecoxib and pregabalin and celecoxib only monotherapy for treatment of chronic low-back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pregabalin 75mg

Trials testing the same drug.

Other recruiting trials for Spinal Stenosis Lumbar

Currently open trials in the same condition.

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03584074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing